MicroRNAs in lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer (LC) is a leading cause of cancer mortality globally, with tobacco smoking as the primary risk factor.
• Despite smoking being a major risk, not all smokers develop LC, indicating other contributing factors.
• Current LC screening focuses on early detection, highlighting the need for novel diagnostic and prognostic markers.

Purpose of the Study:

• To review the current understanding of microRNA alterations in the context of lung cancer.
• To explore the role of microRNAs in key processes such as inflammation, epithelial-mesenchymal transition, and lung disease.
• To discuss the potential of microRNAs in LC pathogenesis, diagnosis, treatment, and prognosis.

Main Methods:

• Literature review of existing research on microRNAs and lung cancer.
• Analysis of microRNA mechanisms involved in cellular processes relevant to cancer.
• Synthesis of information on specific microRNAs implicated in LC initiation and progression.

Main Results:

• MicroRNAs are involved in regulating angiogenesis, cell cycle, proliferation, and apoptosis.
• Alterations in microRNA expression are linked to cancer cell migration and invasion.
• Specific microRNAs show significant association with the initiation and progression of lung cancer.

Conclusions:

• MicroRNA alterations are integral to lung cancer pathogenesis.
• MicroRNAs present promising avenues for improved LC diagnosis and treatment strategies.
• Further research into microRNA functions can enhance our approach to managing lung cancer.